| 摘要 |
A method for inhibiting casein kinase I&egr; activity, comprising administering to said patient a therapeutically effective amount of a compound of formula I. its stereoisomer, enantiomer, racemate, tautomer or pharmaceutically acceptable salt thereof. |
